Terms: = Breast cancer AND BCL3, P20749, 602, ENSG00000069399, D19S37, BCL4 AND Treatment
68 results:
1. Methodology for Using Real-World Data From Electronic Health Records to Assess Chemotherapy Administration in Women With breast cancer.
Bhimani J; O'Connell K; Ergas IJ; Foley M; Gallagher GB; Griggs JJ; Heon N; Kolevska T; Kotsurovskyy Y; Kroenke CH; Laurent CA; Liu R; Nakata KG; Persaud S; Rivera DR; Roh JM; Tabatabai S; Valice E; Bowles EJA; Bandera EV; Kushi LH; Kantor ED
JCO Clin Cancer Inform; 2024 Apr; 8():e2300209. PubMed ID: 38635936
[TBL] [Abstract] [Full Text] [Related]
2. Does Pre-Emptive Availability of PREDICT 2.1 Results Change Ordering Practices for Oncotype DX? A Multi-Center Prospective Cohort Study.
Awan AA; Saunders D; Pond G; Hamm C; Califaretti N; Mates M; Kumar V; Ibrahim MFK; Beltran-Bless AA; Vandermeer L; Hilton J; Clemons M
Curr Oncol; 2024 Feb; 31(3):1278-1290. PubMed ID: 38534929
[TBL] [Abstract] [Full Text] [Related]
3. Clinical Internal Dosimetry and Biodistribution of 177 Lu-DOTA-Trastuzumab in HER2-Positive Metastatic and Locally Advanced breast Carcinoma.
Narwadkar YS; Parghane RV; Sahu S; Lad S; Deep K; Wanage G; Suralkar T; Banerjee S; Gupta S; Basu S; Badwe RA
Clin Nucl Med; 2024 Apr; 49(4):e149-e155. PubMed ID: 38350067
[TBL] [Abstract] [Full Text] [Related]
4. Patient survey on cancer genomic medicine in Japan under the national health insurance system.
Kage H; Akiyama N; Chang H; Shinozaki-Ushiku A; Ka M; Kawata J; Muto M; Okuma Y; Okita N; Tsuchihara K; Kikuchi J; Shirota H; Hayashi H; Kokuryo T; Yachida S; Hirasawa A; Kubo M; Kenmotsu H; Tanabe M; Ushiku T; Muto K; Seto Y; Oda K
Cancer Sci; 2024 Mar; 115(3):954-962. PubMed ID: 38273803
[TBL] [Abstract] [Full Text] [Related]
5. Discovery of a small molecule that inhibits Bcl-3-mediated cyclin D1 expression in melanoma cells.
Saamarthy K; Ahlqvist K; Daams R; Balagunaseelan N; Rinaldo-Matthis A; Kazi JU; Sime W; Massoumi R
BMC Cancer; 2024 Jan; 24(1):103. PubMed ID: 38238702
[TBL] [Abstract] [Full Text] [Related]
6. Trends in Utilization and Medicare Spending on Short-Course Radiation Therapy for breast and Prostate cancer: An Episode-Based Analysis From 2015 to 2019.
Patel TA; Jain B; Vapiwala N; Chino F; Tringale KR; Mahal BA; Yamoah K; McBride SN; Lam MB; Hubbard A; Nguyen PL; Dee EC
Int J Radiat Oncol Biol Phys; 2024 May; 119(1):17-22. PubMed ID: 38072324
[TBL] [Abstract] [Full Text] [Related]
7. Combination of verteporfin-photodynamic therapy with 5-aza-2'-deoxycytidine enhances the anti-tumour immune response in triple negative breast cancer.
Banerjee SM; Acedo P; El Sheikh S; Harati R; Meecham A; Williams NR; Gerard G; Keshtgar MRS; MacRobert AJ; Hamoudi R
Front Immunol; 2023; 14():1188087. PubMed ID: 38022682
[TBL] [Abstract] [Full Text] [Related]
8. The effect of (neo)adjuvant chemotherapy on long-term survival outcomes in patients with invasive lobular breast cancer treated with endocrine therapy: A retrospective cohort study.
Öztekin S; Hooning MJ; van Deurzen CHM; Dietvorst AHP; Drooger JC; Kitzen JJEM; Martens JWM; van der Padt-Pruijsten A; Vastbinder MB; Zuetenhorst H; Heemskerk-Gerritsen BAM; Jager A
Cancer; 2024 Mar; 130(6):927-935. PubMed ID: 37985357
[TBL] [Abstract] [Full Text] [Related]
9. Biotransformation of metenolone acetate and epiandrosterone by fungi and evaluation of resulting metabolites for aromatase inhibition.
Abdul Karim A; Atia-Tul-Wahab ; Aziz A; Shaikh NN; Choudhary MI
Steroids; 2024 Feb; 202():109345. PubMed ID: 37984606
[TBL] [Abstract] [Full Text] [Related]
10. Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trial.
Lundgren C; Tutzauer J; Church SE; Stål O; Ekholm M; Forsare C; Nordenskjöld B; Fernö M; Bendahl PO; Rydén L
Breast Cancer Res; 2023 Sep; 25(1):110. PubMed ID: 37773134
[TBL] [Abstract] [Full Text] [Related]
11. Can inflammatory indices predict sentinel lymph node status in patients with early-stage breast cancer?
Balbaloglu H; Tasdoven I; Karadeniz Cakmak G
Medicine (Baltimore); 2023 Aug; 102(33):e34808. PubMed ID: 37603529
[TBL] [Abstract] [Full Text] [Related]
12. Anthracyclines versus No Anthracyclines in the Neoadjuvant Strategy for HER2+ breast cancer: Real-World Evidence.
de Pinho IS; Luz P; Alves L; Lopes-Brás R; Patel V; Esperança-Martins M; Gonçalves L; Freitas R; Simão D; Galnares MR; Fernandes I; Criado SA; Casado SG; Cañada JB; Vega IMS; Costa JG; Fernandes AS; de Sousa RT; Costa L
Clin Drug Investig; 2023 Sep; 43(9):691-698. PubMed ID: 37479867
[TBL] [Abstract] [Full Text] [Related]
13. Association Between Oncology Clinical Pathway Utilization and Toxicity and Cost Outcomes in Patients With Metastatic Solid Tumors.
Liu Y; Mullangi S; Debono D; Chen X; Pham T; Fisch MJ; Gordon AS; Hershman DL
JCO Oncol Pract; 2023 Sep; 19(9):731-740. PubMed ID: 37384847
[TBL] [Abstract] [Full Text] [Related]
14. Germline Genetic Testing After cancer Diagnosis.
Kurian AW; Abrahamse P; Furgal A; Ward KC; Hamilton AS; Hodan R; Tocco R; Liu L; Berek JS; Hoang L; Yussuf A; Susswein L; Esplin ED; Slavin TP; Gomez SL; Hofer TP; Katz SJ
JAMA; 2023 Jul; 330(1):43-51. PubMed ID: 37276540
[TBL] [Abstract] [Full Text] [Related]
15. Timing of Chemotherapy and Patient-Reported Outcomes After breast-Conserving Surgery and Mastectomy with Immediate Reconstruction.
Pawloski KR; Srour MK; Moo TA; Sevilimedu V; Nelson JA; Garcia P; Kirstein LJ; Morrow M; Tadros AB
Ann Surg Oncol; 2023 May; 30(5):2897-2909. PubMed ID: 36737530
[TBL] [Abstract] [Full Text] [Related]
16. Cosmetic Results and Side Effects of Accelerated Partial-breast Irradiation Versus Whole-breast Irradiation for Low-Risk Invasive Carcinoma of the breast: The Randomized Phase III IRMA Trial.
Meduri B; Baldissera A; Iotti C; Scheijmans LJEE; Stam MR; Parisi S; Boersma LJ; Ammendolia I; Koiter E; Valli M; Scandolaro L; Busz D; Stenfert Kroese MC; Ciabatti S; Giacobazzi P; Ruggieri MP; Engelen A; Munafò T; Westenberg AH; Verhoeven K; Vicini R; D'Amico R; Lohr F; Bertoni F; Poortmans P; Frezza GP
J Clin Oncol; 2023 Apr; 41(12):2201-2210. PubMed ID: 36623246
[TBL] [Abstract] [Full Text] [Related]
17. Reproductive Outcomes in Young breast cancer Survivors Treated (15-39) in Ontario, Canada.
Rushton M; Pudwell J; Wei X; Powell M; Richardson H; Velez MP
Curr Oncol; 2022 Nov; 29(11):8591-8599. PubMed ID: 36421330
[TBL] [Abstract] [Full Text] [Related]
18. Health-related quality of life among breast cancer patients in India.
Gupta N; Pandey AK; Dimri K; Jyani G; Goyal A; Prinja S
Support Care Cancer; 2022 Dec; 30(12):9983-9990. PubMed ID: 36222977
[TBL] [Abstract] [Full Text] [Related]
19. Vimentin and tumor-stroma ratio for neoadjuvant chemoradiotherapy response prediction in locally advanced rectal cancer.
Tian W; Yang Y; Qin Q; Zhang L; Wang Z; Su L; Zeng L; Chen H; Hu L; Hong J; Huang Y; Zhang Q; Zhao H
Cancer Sci; 2023 Feb; 114(2):619-629. PubMed ID: 36221784
[TBL] [Abstract] [Full Text] [Related]
20. Does the 21-gene recurrence score have clinical utility in HR+/HER2+ breast cancer?
Bilani N; Crowley F; Mohanna M; Itani M; Yaghi M; Saravia D; Jabbal I; Dominguez B; Liang H; Nahleh Z
Breast; 2022 Dec; 66():49-53. PubMed ID: 36137495
[TBL] [Abstract] [Full Text] [Related]
[Next]
